Boston Research & Management’s Cintas CTAS Stock Holding History

Boston Research & Management’s Portfolio CTAS Stock Details CTAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.43M	Hold	20,270	–	–	0.81%	54
2025 Q4	$3.81M	Hold	20,270	–	–	0.88%	49
2025 Q3	$4.16M	Hold	20,270	–	–	0.92%	47
2025 Q2	$4.52M	Hold	20,270	–	–	1.08%	43
2025 Q1	$4.17M	Sell	20,270 -1,030	-5%	-$205K	1.03%	47
2024 Q4	$3.89M	Sell	21,300 -500	-2%	-$105K	0.96%	48
2024 Q3	$4.49M	Sell	21,800 -320	-1%	-$61.8K	1.05%	44
2024 Q2	$3.87M	Hold	22,120	–	–	0.98%	50
2024 Q1	$3.8M	Hold	22,120	–	–	0.94%	51
2023 Q4	$3.33M	Hold	22,120	–	–	0.88%	52
2023 Q3	$2.66M	Hold	22,120	–	–	0.79%	54
2023 Q2	$2.75M	Hold	22,120	–	–	0.78%	53
2023 Q1	$2.56M	Hold	22,120	–	–	0.76%	52
2022 Q4	$2.5M	Hold	22,120	–	–	0.77%	52
2022 Q3	$2.15M	Hold	22,120	–	–	0.73%	54
2022 Q2	$2.06M	Hold	22,120	–	–	0.67%	55
2022 Q1	$2.35M	Hold	22,120	–	–	0.68%	56
2021 Q4	$2.45M	Hold	22,120	–	–	0.67%	55
2021 Q3	$2.1M	Hold	22,120	–	–	0.63%	60
2021 Q2	$2.11M	Hold	22,120	–	–	0.64%	56
2021 Q1	$1.89M	Hold	22,120	–	–	0.61%	58
2020 Q4	$1.95M	Hold	22,120	–	–	0.68%	54
2020 Q3	$1.84M	Hold	22,120	–	–	0.72%	49
2020 Q2	$1.47M	Hold	22,120	–	–	0.61%	53
2020 Q1	$957K	Hold	22,120	–	–	0.48%	54
2019 Q4	$1.49M	Hold	22,120	–	–	0.56%	54
2019 Q3	$1.48M	Hold	22,120	–	–	0.59%	52
2019 Q2	$1.31M	Hold	22,120	–	–	0.53%	54
2019 Q1	$1.12M	Hold	22,120	–	–	0.47%	56
2018 Q4	$928K	Hold	22,120	–	–	0.44%	56
2018 Q3	$1.09M	Hold	22,120	–	–	0.5%	59
2018 Q2	$1.02M	Hold	22,120	–	–	0.5%	60
2018 Q1	$943K	Hold	22,120	–	–	0.48%	59
2017 Q4	$861K	Sell	22,120 -3,196	-13%	-$122K	0.43%	59
2017 Q3	$913K	Hold	25,316	–	–	0.47%	58
2017 Q2	$797K	Hold	25,316	–	–	0.43%	58
2017 Q1	$800K	Hold	25,316	–	–	0.44%	60
2016 Q4	$731K	Hold	25,316	–	–	0.42%	62
2016 Q3	$712K	Hold	25,316	–	–	0.41%	60
2016 Q2	$621K	Hold	25,316	–	–	0.38%	63
2016 Q1	$568K	Hold	25,316	–	–	0.35%	66
2015 Q4	$576K	Hold	25,316	–	–	0.36%	69
2015 Q3	$542K	Hold	25,316	–	–	0.36%	72
2015 Q2	$535K	Sell	25,316 -600	-2%	-$12.6K	0.34%	71
2015 Q1	$528K	Hold	25,916	–	–	0.33%	72
2014 Q4	$508K	Hold	25,916	–	–	0.32%	73
2014 Q3	$457K	Hold	25,916	–	–	0.31%	72
2014 Q2	$411K	Hold	25,916	–	–	0.28%	73
2014 Q1	$386K	Hold	25,916	–	–	0.28%	73
2013 Q4	$386K	Hold	25,916	–	–	0.3%	68
2013 Q3	$331K	Hold	25,916	–	–	0.28%	71
2013 Q2	$295K	Buy	+25,916	New	+$292K	0.26%	74

Other funds holding CTAS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boston Research & Management's CTAS Position: Q1 2026 in Review

Boston Research & Management held its Cintas (CTAS) position steady in Q1 2026 at 20,270 shares worth $3.43M. The position accounts for 0.81% of the portfolio, ranked #54.

Boston Research & Management first reported a position in CTAS in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.52M in Q2 2025. 1,429 funds tracked by Wall St. Rank hold CTAS as of Q1 2026.

Boston Research & Management held 20,270 shares of Cintas worth $3.43M as of Q1 2026.
Boston Research & Management left its Cintas share count unchanged in Q1 2026.
Cintas made up 0.81% of Boston Research & Management's portfolio in Q1 2026, its #54 holding.
Boston Research & Management first reported a position in Cintas in Q2 2013 and has held it in 52 quarters since.
Boston Research & Management's Cintas position peaked at $4.52M in Q2 2025.
1,429 funds tracked by Wall St. Rank held Cintas as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.